Viemed Healthcare (VMD) Operating Expenses (2018 - 2026)

On a trailing twelve-month basis, Viemed Healthcare's Operating Expenses was $138.52 million through Jun 30, 2026, up 20.1% year-over-year; for FY2025, it was $124.38 million, up 13.8% from FY2024.

• Operating Expenses has now increased for seven consecutive years, with a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
• In earlier years, Operating Expenses was $109.27 million in FY2024 (+20.5%), $90.67 million in FY2023 (+4.8%), $86.49 million in FY2022 (+26.6%) and $68.32 million in FY2021 (+7.6%).
• The Q2 2026 figure marks the highest quarterly Operating Expenses in data going back to Q1 2018.
• Compared with a year earlier, Operating Expenses has increased for 20 straight quarters, with growth averaging 16.6% over the last eight quarters.
• The year-over-year growth in Operating Expenses has ranged between 0.4% (Q3 2021) and 34.9% (Q2 2022) over the last five years.
• Per Business Quant data, VMD's Operating Expenses in the three quarters before Q2 2026 was $35.37 million (Q1 2026), $32.82 million (Q4 2025) and $32.69 million (Q3 2025).